AU Stock MarketDetailed Quotes
ZLD Zelira Therapeutics Ltd
- 0.730
- -0.040-5.19%
20min DelayMarket Closed Jul 19 15:51 AET
8.28MMarket Cap-1317P/E (Static)
0.780High0.730Low10.90KVolume0.770Open0.770Pre Close8.21KTurnover1.80052wk High0.18%Turnover Ratio11.35MShares0.28052wk Low-3.236EPS TTM4.50MFloat Cap5625176.649Historical HighLossP/E (Static)6.16MShs Float0.280Historical Low-0.554EPS LYR6.49%Amplitude--Dividend TTM-3.54P/B1Lot Size--Div YieldTTM
About Zelira Therapeutics Ltd Company
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.
Company Profile
SymbolZLD
Company NameZelira Therapeutics Ltd
Founded2003
MarketASX
Employees8
Fiscal Year Ends06-30
Address101 St George’s Terrace Level 3
CityPerth
CountryAustralia
Zip Code6000
Phone+61 865580886
Websitehttps://www.zeliratx.com
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED
Level 17, 221 St Georges Terrace, PERTH, WA, AUSTRALIA, 6000
1300 850 505
Company Executives
- Name
- Position
- Salary
- Osagie Imasogie
- Non-Executive Chairman of the Board
- --
- Oludare Odumosu
- Managing Director and Director
- --
- Greg Blake
- Executive Director
- --
- Donna Gentile O'Donnell
- Non-Executive Director
- --
- Timothy (Tim) Ryan Slate
- Company Secretary and Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg